Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd has announced an update regarding its ongoing buy-back program, specifically detailing the daily buy-back activity. As of March 18, 2025, the company has repurchased a total of 2,517,609 ordinary fully paid securities, including 4,672 securities bought back on the previous day. This buy-back initiative is part of Cogstate’s strategy to optimize its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in cognitive assessment and technology solutions. The company focuses on providing cognitive testing services and software to support clinical trials, healthcare providers, and researchers in understanding and measuring cognitive function.
YTD Price Performance: 22.22%
Average Trading Volume: 9,438
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $154.6M
For detailed information about CGS stock, go to TipRanks’ Stock Analysis page.